References
- Arni R. K., Ward R. J. Phospholipase A2—a structural review. Toxicon 1996; 34(8)827–841
- Balsinde J., Balboa M. A., Insel P. A., Dennis E. A. Regulation and inhibition of phospholipase A2. Annu. Rev. Pharmacol. Toxicol. 1999; 39: 175–189
- Capper E. A., Marshall L. A. Mammalian phospholipases A2: mediators of inflammation, proliferation and apotopsis. Prog. Lipid Res. 2001; 40: 167–197
- Chen J. P., Chen J. Y. Preparation and characterization of immobilized phospholipase A2 on chitosan beads for lowering serum cholesterol concentration. J. Mol. Catal., B: Enzym. 1998; 5: 483–490
- Dennis E. A. Diversity of group types regulation and function of phospholipase A2. J. Biol. Chem. 1994; 269: 13057–13060
- Ferreira J. P., Sasisekharan R., Louie, Langer R. Influence of chemistry in immobilization of cobra venom phospholipase A2: implications as to mechanism. Biochemistry 1993; 32(32)8098–8102
- Janowski F., Fischer G. Aminopropylsilane treatment for the surface of porous glasses suitable for enzyme immobilization. J. Chem. Technol. Biotechnol. 1991; 51: 263–272
- Kaiser E. Phospholipase A2: its usefulness in laboratory diagnostics. Crit. Rev. Clin. Lab. Sci. 1999; 36(2)65–163
- Kim J., Lee C. S., Oh J., Kim B. G. Production of egg yolk lysolecithin with immobilized phospholipase A2. Enzyme Microb. Technol. 2001; 29: 587–592
- Labeque R., Mullan C. J.P., Efeerira J. P.M., Lees R. S., Langer R. Enzymatic modification of plasma low density lipoproteins in rabbits: a potential treatment for hypercholesterolemia. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 3476–3480
- Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265–275
- Madoery R. R., Fidelio G. D. A simple method to obtain a covalent immobilized phospholipase A2. Bioorg. Med. Chem. Lett. 2001; 11: 1663–1664
- Madoery R. R., Gattone C. G., Fidelio G. Bioconversion of phospholipids by immobilized phospholipase A2. J. Biotechnol. 1995; 40: 145–153
- Mukherjee K. Phospholipase catalyzed reactions. Biocatalysis 1990; 3: 288–293
- Shefer S. D., Breslau J., Langer R. Computer simulation of low density lipoprotein removal in the presence of a bioreactor containing phospholipase A2. Biotechnol. Prog. 1995a; 1: 133–139
- Shefer S. D., Rosenberger V., Vahanian G., Wong W. T., Langer R. Implantable hollow fiber bioreactor as a potantial treatment for hypercholesterolemia: characterization of the catalytic unit. Biotechnol. Bioeng. 1995b; 48: 36–41
- Shen Z., Cho W. Highly efficient immobilization of phospholipase A2 and its biomedical applications. J. Lipid Res. 1995; 36(5)1147–1151
- Simonsson E., Ahren B. Phospholipase A2 and its potential regulation of islet function. Int. J. Pancreatol. 2000; 27(1)1–11
- Siso M. I.G., Lang E., Gomez B. J., Becerra M., Espinar F. O., Mendez J. B. Enzyme encapsulation on chitosan membranes. Process Biochem. 1997; 32: 211–216
- Six D. A., Dennis E. A. The expanding superfamily of phospholipase A2 enzymes: classification and characterization. Biochim. Biophys. Acta 2000; 1488: 1–19
- Tai L. K., Cooper E.. Use of Monoacylphosphoglicerids to Enhance the Corneal Penetration of Ophtalmic Drugs. CA, 114, 108919t. PCT Int. Appl. WO 90 11,070 (Cl.A61 K31/685), 04 Oct. 1990
- Vaillant F., Millan A., Millan P., Dornier M., Decloux M., Reynes M. Co‐immobilized pectinlyase and endocellulase on chitin and nylon supports. Process Biochem. 2000; 35: 989–996
- Weethall H. H. Preparation of immobilized proteins covalenty coupled through silane coupling agents to inorganic supports. Appl. Biochem. Biotechnol. 1993; 41: 157–188
- Yedgar S., Lichtenberg D., Schnitzer E. Inhibition of phospholipase A2 as a therapeutic target. Biochim. Biophys. Acta 2000; 1488: 182–187